<DOC>
	<DOCNO>NCT01227538</DOCNO>
	<brief_summary>Type 1 diabetes condition progressive autoimmune destruction insulin-producing beta-cells lead absolute insulin deficiency . At time clinical presentation , estimate 50-80 % beta-cell function lose . Good glycaemic control diagnosis show preserve beta-cell function . The recent identification immuno-interventions able reduce autoimmune destruction preserve beta-cell function lead increase urgency develop tool . With mixed-meal stimulated serum C-peptide gold standard , currently test suit use clinical practice detect monitor residual beta cell function . There therefore need test sufficiently sensitive ass beta cell function reserve Type 1 diabetes clinical practice purpose , simple , reproducible suitable use even non-observed setting . Using mixed meal stimulation plasma C-peptide ( stable by-product insulin secretion reliably reflect insulin production ) response reference , propose compare mixed meal stimulate urinary C-peptide potential candidate application . This pilot investigation sample 30 participant recruit . It anticipate current project identify simple method analyse beta cell reserve Type 1 diabetes . This applied screening clinic population recently diagnose patient type 1 diabetes . The aim identify subject may suitable early intensified insulin regime ( e.g . insulin pump therapy ) novel immuno-intervention strategy design preserve residual beta cell function improve long-term outcome . Currently immunointervention reserve subject within 3 month diagnosis , exclude significant number subject may potentially benefit .</brief_summary>
	<brief_title>Towards Simple Non-invasive Assessment Residual Beta-cell Function Type 1 Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<criteria>1 . 1 . Type 1 diabetes diagnose last 5 year 2 . Age 1845 year 3 . BMI 18.5 29.9 4 . Insulin requirement le 0.8 units/kg 1 . HbA1c high 10 % 2 . Ongoing steroid treatment chemotherapy 3 . Pregnancy breast feed 4. eGFR less 50ml/min/1.73m2</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>Beta cell reserve , urinary C peptide</keyword>
</DOC>